John L. Higgins
Equibles does not estimate personal net worth.
About John L. Higgins
Earlier roles on record: Board Member at Ligand Pharmaceuticals Inc (LGND) until December 31, 2022 and CEO at Ligand Pharmaceuticals Inc (LGND) until December 5, 2022. Ligand Pharmaceuticals Inc reported in an 8-K filed December 5, 2022 that John L. Higgins resigned as member of the Board, effective December 31, 2022. Ligand Pharmaceuticals Inc reported in an 8-K filed December 5, 2022 that John L. Higgins retired as Chief Executive Officer, effective December 5, 2022. The proxy statement of Ligand Pharmaceuticals Inc reports total compensation of $16,764,990 for John L. Higgins in fiscal 2022, including a base salary of $675,264. Disclosed compensation is on record for 6 fiscal years.
“Mr. Higgins also resigned as a member of the Board, effective December 31, 2022.”
“On December 5, 2022, Ligand Pharmaceuticals Incorporated (the "Company") announced that John L. Higgins has retired as Chief Executive Officer of the Company, and that Todd C. Davis was appointed Chief Executive Officer of the Company, each effective as of December 5, 2022.”
Affiliation history
-
2022-06-13–2022-12-31
-
Start not stated–2022-12-05
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Ligand Pharmaceuticals Inc (LGND) | Former Chief Executive Officer | $675,264 | $16,764,990 |
| 2021 | Ligand Pharmaceuticals Inc (LGND) | Former Chief Executive Officer | $696,583 | $9,587,211 |
| 2020 | Ligand Pharmaceuticals Inc (LGND) | Former Chief Executive Officer | $668,333 | $5,842,767 |
| 2019 | Ligand Pharmaceuticals Inc (LGND) | Chief Executive Officer | $648,192 | $6,770,376 |
| 2018 | Ligand Pharmaceuticals Inc (LGND) | Chief Executive Officer | $627,413 | $6,306,803 |
| 2017 | Ligand Pharmaceuticals Inc (LGND) | Chief Executive Officer | $611,656 | $5,513,207 |